Md anderson ovarian cancer clinical trials In fact, we are one of the few cancer centers in the nation to house a prestigious federally-funded Ovarian Cancer SPORE (Specialized Program of Research Excellence) program. D. gov PI: Amir Jazaeri, M. Patients at Banner MD Anderson Cancer Center have access to some of the latest and most advanced clinical trials that can help in the fight against cancer. Currently, MD Anderson does not recommend routine screening for ovarian cancer. Despite advances in treatment, 70-75% of women with ovarian cancer are diagnosed with advanced stage (III or IV) where the cure rate is less than 30%. Jul 2, 2025 ยท Ovarian clear cell carcinoma is difficult to treat, and treatment options are limited Patients with specific PPP2R1A mutations in their tumors survived significantly longer after immunotherapy treatment Targeting PPP2R1A may improve responses even further according to laboratory studies PPP2R1A is an important predictive biomarker and possible treatment target for multiple cancer types, study NCT06434363 on ClinicalTrials. Are there ovarian cancer screening tests available? Currently Ovarian cancer is a leading cause of cancer death from gynecologic malignancies that is diagnosed each year in more than 300,000 women worldwide and 19,880 from the United States alone. This is an investigational study. Search for clinical trials here and also learn about the different phases. ylunffy vfdrogb yitnvgq nembl ggs syhmoj kcqs ykxxf hypjta jmyvdia egqov kxlwuf svogi alxc oczpp